Invesco’s Aratana Therapeutics PETX Stock Holding History
Bought
Maintained
Sold
Other funds holding PETX
AIC
Invesco's PETX Position: Q1 2017 in Review
Invesco sold out of Aratana Therapeutics (PETX) in Q1 2017, closing a stake of 160,933 shares — an estimated $1.16M sold.
Invesco first reported a position in PETX in Q2 2015 and held it in 2 quarters. The position peaked at $1.16M in Q4 2016. 98 funds tracked by Wall St. Rank hold PETX as of Q1 2017.
- Invesco reported no remaining Aratana Therapeutics position as of Q1 2017 after selling out during the quarter.
- Invesco sold 160,933 Aratana Therapeutics shares in Q1 2017, an estimated $1.16M.
- Invesco first reported a position in Aratana Therapeutics in Q2 2015 and held it in 2 quarters.
- Invesco's Aratana Therapeutics position peaked at $1.16M in Q4 2016.
- 98 funds tracked by Wall St. Rank held Aratana Therapeutics as of Q1 2017.
Based on Invesco's 13F filing for Q1 2017, filed 15 May 2017.